SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Evan J. Kyzar, Adam Michael Stewart, Allan V. Kalueff, Effects of LSD on grooming behavior in serotonin transporter heterozygous (Sert+/−) mice, Behavioural Brain Research, 2016, 296, 47

    CrossRef

  2. 2
    Patrick C. Dolder, Yasmin Schmid, Manuel Haschke, Katharina M. Rentsch, Matthias E. Liechti, Pharmacokinetics and Concentration-Effect Relationship of Oral LSD in Humans, International Journal of Neuropsychopharmacology, 2016, 19, 1, pyv072

    CrossRef

  3. 3
    Simon D. Brandt, Pierce V. Kavanagh, Folker Westphal, Alexander Stratford, Simon P. Elliott, Khoa Hoang, Jason Wallach, Adam L. Halberstadt, Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD), Drug Testing and Analysis, 2016, 8, 2
  4. 4
    Patrick J. Maher, Fiona E. Gallahue, Ciottone's Disaster Medicine, 2016,

    CrossRef

  5. 5
    Yasmin Schmid, Florian Enzler, Peter Gasser, Eric Grouzmann, Katrin H. Preller, Franz X. Vollenweider, Rudolf Brenneisen, Felix Müller, Stefan Borgwardt, Matthias E. Liechti, Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects, Biological Psychiatry, 2015, 78, 8, 544

    CrossRef

  6. 6
    Dimitrius L. Pitol, Selma Siéssere, Rafael G. dos Santos, Maria L. N. M. Rosa, Jaime E. C. Hallak, Priscilla H. Scalize, Bruno F. Pereira, Melina M. Iyomasa, Marisa Semprini, Jordi Riba, Simone C. H. Regalo, Ayahuasca Alters Structural Parameters of the Rat Aorta, Journal of Cardiovascular Pharmacology, 2015, 66, 1, 58

    CrossRef

  7. 7
    Patrick C. Dolder, Matthias E. Liechti, Katharina M. Rentsch, Development and validation of a rapid turboflow LC-MS/MS method for the quantification of LSD and 2-oxo-3-hydroxy LSD in serum and urine samples of emergency toxicological cases, Analytical and Bioanalytical Chemistry, 2015, 407, 6, 1577

    CrossRef

  8. 8
    Philippe Guerre, Ergot Alkaloids Produced by Endophytic Fungi of the Genus Epichloë, Toxins, 2015, 7, 3, 773

    CrossRef

  9. 9
    M. Kaelen, F. S. Barrett, L. Roseman, R. Lorenz, N. Family, M. Bolstridge, H. V. Curran, A. Feilding, D. J. Nutt, R. L. Carhart-Harris, LSD enhances the emotional response to music, Psychopharmacology, 2015, 232, 19, 3607

    CrossRef

  10. 10
    Sharon Moran, Jason Isa, Susan Steinemann, Perioperative Management in the Patient with Substance Abuse, Surgical Clinics of North America, 2015, 95, 2, 417

    CrossRef

  11. 11
    Anna Rickli, Dino Luethi, Julian Reinisch, Danièle Buchy, Marius C. Hoener, Matthias E. Liechti, Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs), Neuropharmacology, 2015, 99, 546

    CrossRef

  12. 12
    Moonhee Jang, Jihyun Kim, Inhoi Han, Wonkyung Yang, Simultaneous determination of LSD and 2-oxo-3-hydroxy LSD in hair and urine by LC–MS/MS and its application to forensic cases, Journal of Pharmaceutical and Biomedical Analysis, 2015, 115, 138

    CrossRef

  13. 13
    Joji Suzuki, Michael A. Dekker, Erin S. Valenti, Fabiola A. Arbelo Cruz, Ady M. Correa, Justin L. Poklis, Alphonse Poklis, Toxicities Associated With NBOMe Ingestion—A Novel Class of Potent Hallucinogens: A Review of the Literature, Psychosomatics, 2015, 56, 2, 129

    CrossRef

  14. 14
    Rohin Francis, Azad Ghuran, Heart and Toxins, 2015,

    CrossRef

  15. 15
    Michael James Winkelman, Exploring Psychedelic Trance and Electronic Dance Music in Modern Culture, 2015,

    CrossRef

  16. 16
    Joji Suzuki, Justin L. Poklis, Alphonse Poklis, “My Friend Said it was Good LSD”: A Suicide Attempt Following Analytically Confirmed 25I-NBOMe Ingestion, Journal of Psychoactive Drugs, 2014, 46, 5, 379

    CrossRef

  17. 17
    John C. Talpos, Nancy Aerts, Laetitia Fellini, Thomas Steckler, A touch-screen based paired-associates learning (PAL) task for the rat may provide a translatable pharmacological model of human cognitive impairment, Pharmacology Biochemistry and Behavior, 2014, 122, 97

    CrossRef

  18. 18
    M. E. Sutter, J. Chenoweth, T. E. Albertson, Alternative Drugs of Abuse, Clinical Reviews in Allergy & Immunology, 2014, 46, 1, 3

    CrossRef

  19. 19
    Daniele Merli, Daniele Zamboni, Stefano Protti, Maria Pesavento, Antonella Profumo, Electrochemistry and analytical determination of lysergic acid diethylamide (LSD) via adsorptive stripping voltammetry, Talanta, 2014, 130, 456

    CrossRef

  20. 20
    Yves P. Auberson, Thomas Troxler, Xuechun Zhang, Charles R. Yang, Markus Fendt, Dominik Feuerbach, Yu-Chih Liu, Bharat Lagu, Andreas Lerchner, Mark Perrone, Lijun Lei, Chao Zhang, Chunxiu Wang, Tie-Lin Wang, Mark G. Bock, Ergoline-Derived Inverse Agonists of the Human H3 Receptor for the Treatment of Narcolepsy, ChemMedChem, 2014, 9, 8
  21. 21
    Ruud P.W. Litjens, Tibor M. Brunt, Gerard-Jan Alderliefste, Remco H.S. Westerink, Hallucinogen persisting perception disorder and the serotonergic system: A comprehensive review including new MDMA-related clinical cases, European Neuropsychopharmacology, 2014, 24, 8, 1309

    CrossRef

  22. 22
    Amelie Govare, Elizabeth Leroux, Licit and Illicit Drug Use in Cluster Headache, Current Pain and Headache Reports, 2014, 18, 5

    CrossRef

  23. 23
    Aaron Janowsky, Amy J. Eshleman, Robert A. Johnson, Katherine M. Wolfrum, David J. Hinrichs, Jongtae Yang, T. Mark Zabriskie, Martin J. Smilkstein, Michael K. Riscoe, Mefloquine and psychotomimetics share neurotransmitter receptor and transporter interactions in vitro, Psychopharmacology, 2014, 231, 14, 2771

    CrossRef

  24. 24
    Silja Skogstad Tuv, Hege Krabseth, Ritva Karinen, Kirsten M. Olsen, Elisabeth L. Øiestad, Vigdis Vindenes, Prevalence of synthetic cannabinoids in blood samples from Norwegian drivers suspected of impaired driving during a seven weeks period, Accident Analysis & Prevention, 2014, 62, 26

    CrossRef

  25. 25
    Peter Gasser, Dominique Holstein, Yvonne Michel, Rick Doblin, Berra Yazar-Klosinski, Torsten Passie, Rudolf Brenneisen, Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases, The Journal of Nervous and Mental Disease, 2014, 202, 7, 513

    CrossRef

  26. 26
    Patrick Dawson, Jolanta Opacka-Juffry, James D Moffatt, Yusuf Daniju, Neelakshi Dutta, John Ramsey, Colin Davidson, The effects of benzofury (5-APB) on the dopamine transporter and 5-HT2-dependent vasoconstriction in the rat, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2014, 48, 57

    CrossRef

  27. 27
    C.M. Stork, B. Henriksen, Encyclopedia of Toxicology, 2014,

    CrossRef

  28. 28
    Drugs of Abuse, 2014,

    CrossRef

  29. 29
    Jacob Peedicayil, Erbo Dong, Dennis R. Grayson, Epigenetics in Psychiatry, 2014,

    CrossRef

  30. 30
    Brittany Vasae Burdick, Bryon Adinoff, A proposal to evaluate mechanistic efficacy of hallucinogens in addiction treatment, The American Journal of Drug and Alcohol Abuse, 2013, 39, 5, 291

    CrossRef

  31. 31
    T. Berg, B. Jorgenrud, D. H. Strand, Determination of Buprenorphine, Fentanyl and LSD in Whole Blood by UPLC-MS-MS, Journal of Analytical Toxicology, 2013, 37, 3, 159

    CrossRef

  32. 32
    Emmanuelle A.D. Schindler, John A. Harvey, Vincent J. Aloyo, Phospholipase C mediates (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-, but not lysergic acid diethylamide (LSD)-elicited head bobs in rabbit medial prefrontal cortex, Brain Research, 2013, 1491, 98

    CrossRef

  33. 33
    Christian Blacha, Markus M. Schmid, Maximilian Gahr, Roland W. Freudenmann, Paul L. Plener, Florian Finter, Bernhard J. Connemann, Carlos Schönfeldt-Lecuona, Self-inflicted Testicular Amputation in First Lysergic Acid Diethylamide Use, Journal of Addiction Medicine, 2013, 7, 1, 83

    CrossRef

  34. 34
    Sailaja A. Goda, Joanna Piasecka, Maciej Olszewski, Stefan Kasicki, Mark J. Hunt, Serotonergic hallucinogens differentially modify gamma and high frequency oscillations in the rat nucleus accumbens, Psychopharmacology, 2013, 228, 2, 271

    CrossRef

  35. 35
    Patrick Dawson, James D. Moffatt, Cardiovascular toxicity of novel psychoactive drugs: Lessons from the past, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2012, 39, 2, 244

    CrossRef

  36. 36
    Luana Lionetto, Andrea Negro, Stefano Palmisani, Giovanna Gentile, Maria Rosaria Del Fiore, Marco Mercieri, Maurizio Simmaco, Thomas Smith, Adnan Al-Kaisy, Roberto Arcioni, Paolo Martelletti, Emerging treatment for chronic migraine and refractory chronic migraine, Expert Opinion on Emerging Drugs, 2012, 17, 3, 393

    CrossRef

  37. 37
    T. C. Butler, M. Benayoun, E. Wallace, W. van Drongelen, N. Goldenfeld, J. Cowan, Evolutionary constraints on visual cortex architecture from the dynamics of hallucinations, Proceedings of the National Academy of Sciences, 2012, 109, 2, 606

    CrossRef

  38. 38
    Christopher Sinke, John H. Halpern, Markus Zedler, Janina Neufeld, Hinderk M. Emrich, Torsten Passie, Genuine and drug-induced synesthesia: A comparison, Consciousness and Cognition, 2012, 21, 3, 1419

    CrossRef

  39. 39
    Guilherme Nogueira M de Oliveira, João Vinícius Salgado, Izabela Guimarães Barbosa, Antônio Lúcio Teixeira, George Harrison's Inner Light, Revista Brasileira de Psiquiatria, 2012, 34, 4, 517

    CrossRef

  40. 40
    Vigdis Vindenes, Dag Jordbru, Arne-Birger Knapskog, Elena Kvan, Grete Mathisrud, Lars Slørdal, Jørg Mørland, Impairment based legislative limits for driving under the influence of non-alcohol drugs in Norway, Forensic Science International, 2012, 219, 1-3, 1

    CrossRef

  41. 41
    Melissa M. Gomes, Felipe A. Dörr, Luiz H. Catalani, Ana Campa, Oxidation of lysergic acid diethylamide (LSD) by peroxidases: a new metabolic pathway, Forensic Toxicology, 2012, 30, 2, 87

    CrossRef

  42. 42
    Emmanuelle A.D. Schindler, Kuldip D. Dave, Elaine M. Smolock, Vincent J. Aloyo, John A. Harvey, Serotonergic and dopaminergic distinctions in the behavioral pharmacology of (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD), Pharmacology Biochemistry and Behavior, 2012, 101, 1, 69

    CrossRef

  43. 43
    Cecilie L. Licht, Maria Christoffersen, Mads Okholm, Lærke Damgaard, Anders Fink-Jensen, Gitte M. Knudsen, David Erritzoe, Simultaneous polysubstance use among Danish 3,4-methylenedioxymethamphetamine and hallucinogen users: combination patterns and proposed biological bases, Human Psychopharmacology: Clinical and Experimental, 2012, 27, 4
  44. 44
    Markus R Meyer, Hans H Maurer, Absorption, distribution, metabolism and excretion pharmacogenomics of drugs of abuse, Pharmacogenomics, 2011, 12, 2, 215

    CrossRef

  45. 45
    Jin-Jye Feng, Fong-Chi Cheng, Chun-Hsiung Lin, Jiann-Wu Wei, Shiaw-Der Yang, Characterization of 5-HT transporter and receptor system in HeLaS3 cells by [3H]8-OH-DPAT and other serotonergic ligands, Archives of Biochemistry and Biophysics, 2011, 506, 1, 66

    CrossRef

  46. 46
    Beatriz Caiuby Labate, Consumption of Ayahuasca by Children and Pregnant Women: Medical Controversies and Religious Perspectives, Journal of Psychoactive Drugs, 2011, 43, 1, 27

    CrossRef

  47. 47
    Wolfgang Blenau, Markus Thamm, Distribution of serotonin (5-HT) and its receptors in the insect brain with focus on the mushroom bodies. Lessons from Drosophila melanogaster and Apis mellifera, Arthropod Structure & Development, 2011, 40, 5, 381

    CrossRef

  48. 48
    Eric P. Baron, Stewart J. Tepper, Response, Headache: The Journal of Head and Face Pain, 2011, 51, 2
  49. 49
    Stefanie Lis, Jannis Apostolopoulos, Peter Kirsch, Bernd Gallhofer, Sensory and Motor Encoding Strategies in n-Back Tasks: A Simulation of Schizophrenic Working Memory Deficits in Healthy Subjects, Neuropsychobiology, 2011, 63, 3, 137

    CrossRef

  50. 50
    Jørgen G. Bramness, Tendensiøst om LSD, Tidsskrift for Den norske legeforening, 2011, 131, 2, 152

    CrossRef

  51. 51
    Levente Móró, Katalin Simon, Imre Bárd, József Rácz, Voice of the Psychonauts: Coping, Life Purpose, and Spirituality in Psychedelic Drug Users, Journal of Psychoactive Drugs, 2011, 43, 3, 188

    CrossRef

  52. 52
    Matthew R. Pincus, Naif Z. Abraham, Henry's Clinical Diagnosis and Management by Laboratory Methods, 2011,

    CrossRef

  53. 53
    Josep Maria Fábregas, Débora González, Sabela Fondevila, Marta Cutchet, Xavier Fernández, Paulo César Ribeiro Barbosa, Miguel Ángel Alcázar-Córcoles, Manel J. Barbanoj, Jordi Riba, José Carlos Bouso, Assessment of addiction severity among ritual users of ayahuasca, Drug and Alcohol Dependence, 2010, 111, 3, 257

    CrossRef

  54. 54
    Leah Grossman, Eli Utterback, Adam Stewart, Siddharth Gaikwad, Kyung Min Chung, Christopher Suciu, Keith Wong, Marco Elegante, Salem Elkhayat, Julia Tan, Thomas Gilder, Nadine Wu, John DiLeo, Jonathan Cachat, Allan V. Kalueff, Characterization of behavioral and endocrine effects of LSD on zebrafish, Behavioural Brain Research, 2010, 214, 2, 277

    CrossRef

  55. 55
    M.K.S. Shbair, S. Eljabour, I. Bassyoni, M. Lhermitte, Drugs involved in drug-facilitated crimes – part II: Drugs of abuse, prescription and over-the-counter medications. A review, Annales Pharmaceutiques Françaises, 2010, 68, 6, 319

    CrossRef

  56. 56
    Zachary Berrens, Jessica Lammers, Christopher White, Rhabdomyolysis After LSD Ingestion, Psychosomatics, 2010, 51, 4, 356

    CrossRef

  57. 57
    Rafael Guimarães dos Santos, Toxicity of chronic ayahuasca administration to the pregnant rat: how relevant it is regarding the human, ritual use of ayahuasca?, Birth Defects Research Part B: Developmental and Reproductive Toxicology, 2010, 89, 6
  58. 58
    Markus R. Meyer, Hans H. Maurer, Drugs of Abuse (Including Designer Drugs),
  59. 59
    Lysergic Acid Diethylamide (LSD),
  60. 60
    Thomas B. Roberts, Michael J. Winkelman, Psychedelic Induced Transpersonal Experiences, Therapies, and Their Implications for Transpersonal Psychology,
  61. 61
    References,